Why the study?
Does oral pancreatic enzyme replacement therapy improve appetite loss in patients with chronic heart failure?
Population
Patients with chronic heart failure (CHF) experiencing appetite loss and pancreatic exocrine insufficiency
Design
Other
Authors
Loading...
May support enzyme replacement for HF appetite loss; leaves open confirmation in randomized trials.
Does oral pancreatic enzyme replacement therapy improve appetite loss in patients with chronic heart failure?
Oral pancreatic enzyme replacement therapy may attenuate appetite loss in patients with chronic heart failure, highlighting a potential pancreatic-cardiac relationship.
Xia et al. (2017) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: